Many researchers tried to develop IHC techniques that are able to identify HER2 with a sufficient precision and therefore be able to help the pathologist with the characterization of breast cancer [5,6,7,8,9,10,11,12,13]. This evidence concerns the gene ERBB2 and breast cancer.